A clinical grading system based on ultra-wide field retinal imaging for sunset glow fundus in Vogt-Koyanagi-Harada Disease

  • Eun Kyoung Lee
  • Sang-Yoon Lee
  • Hyeong Gon Yu
Retinal Disorders



To develop a grading system for sunset glow fundus (SGF) based on the results of ultra-wide field retinal imaging and to investigate the factors related to the severity of SGF in patients with Vogt-Koyanagi-Harada (VKH) disease.


Records of 55 eyes with VKH disease were retrospectively reviewed. All patients had undergone serial fundus photography, ultra-wide field retinal imaging and spectral-domain optical coherence tomography. The morphologic characteristics of SGF and associated features related to the severity of the condition were evaluated.


Sunset glow fundi were classified into 3 groups based on the extent and severity of depigmentary changes: early (n = 7), intermediate (n = 10) and advanced (n = 20). Grade 0 indicates the absence of sunset glow appearance. Eyes with a higher SGF grade were more likely to exhibit chronic recurrence (P < 0.001) and an anterior chamber reaction ≥ 2+ (P < 0.001), and were less likely to exhibit exudative retinal detachment (P < 0.001) at the initial presentation. Higher grades were more likely to exhibit cataracts (P < 0.001), glaucoma (P = 0.010), patchy chorioretinal atrophic lesions (P = 0.012), depigmented atrophic lesions (P < 0.001), an increased peripapillary atrophy/disc area ratio (P < 0.001), a decreased subfoveal choroidal thickness (P < 0.001), more frequent uveitis recurrences (P = 0.012) and a longer disease duration (P < 0.001). SGF progression was faster in eyes with a longer active inflammatory period.


We present a simple and logical grading system for SGF as determined by using ultra-wide field retinal imaging. This grading system offers a means of assessing the degree of inflammation and facilitates speculation about the duration of VKH disease.


Clinical grading system Sunset glow fundus Ultra-wide field retinal imaging Vogt-Koyanagi-Harada disease 



No conflicting relationship exists for any author.

Financial Support



  1. 1.
    Yamaki K, Hara K, Sakuragi S (2005) Application of revised diagnostic criteria for vogt-koyanagi-harada disease in Japanese patients. Jpn J Ophthalmol 49(2):143–148CrossRefPubMedGoogle Scholar
  2. 2.
    Kitamura M, Takami K, Kitaichi N, Namba K, Kitamei H, Kotake S, Ohno S (2005) Comparative study of two sets of criteria for the diagnosis of Vogt-Koyanagi-Harada’s disease. Am J Ophthalmol 139(6):1080–1085CrossRefPubMedGoogle Scholar
  3. 3.
    Moorthy RS, Inomata H, Rao NA (1995) Vogt-Koyanagi-Harada syndrome. Surv Ophthalmol 39(4):265–292CrossRefPubMedGoogle Scholar
  4. 4.
    Keino H, Goto H, Usui M (2002) Sunset glow fundus in Vogt-Koyanagi-Harada disease with or without chronic ocular inflammation. Graefes Arch Clin Exp Ophthalmol 240(10):878–882CrossRefPubMedGoogle Scholar
  5. 5.
    Rao NA, Gupta A, Dustin L, Chee SP, Okada AA, Khairallah M, Bodaghi B, Lehoang P, Accorinti M, Mochizuki M, Prabriputaloong T, Read RW (2010) Frequency of distinguishing clinical features in Vogt-Koyanagi-Harada disease. Ophthalmology 117(3):591–599CrossRefPubMedCentralPubMedGoogle Scholar
  6. 6.
    Keino H, Goto H, Mori H, Iwasaki T, Usui M (2006) Association between severity of inflammation in CNS and development of sunset glow fundus in Vogt-Koyanagi-Harada disease. Am J Ophthalmol 141(6):1140–1142CrossRefPubMedGoogle Scholar
  7. 7.
    Takahashi H, Takase H, Ishizuka A, Miyanaga M, Kawaguchi T, Ohno-Matsui K, Mochizuki M (2013) Choroidal Thickness in Convalescent Vogt-Koyanagi-Harada Disease. Retina 34(4):775–780Google Scholar
  8. 8.
    Kaines A, Tsui I, Sarraf D, Schwartz S (2009) The use of ultra wide field fluorescein angiography in evaluation and management of uveitis. Semin Ophthalmol 24(1):19–24CrossRefPubMedGoogle Scholar
  9. 9.
    Manivannan A, Plskova J, Farrow A, McKay S, Sharp PF, Forrester JV (2005) Ultra-wide-field fluorescein angiography of the ocular fundus. Am J Ophthalmol 140(3):525–527CrossRefPubMedGoogle Scholar
  10. 10.
    Leder HA, Campbell JP, Sepah YJ, Gan T, Dunn JP, Hatef E, Cho B, Ibrahim M, Bittencourt M, Channa R, Do DV, Nguyen QD (2013) Ultra-wide-field retinal imaging in the management of non-infectious retinal vasculitis. J Ophthalmic Inflamm Infect 3(1):30CrossRefPubMedCentralPubMedGoogle Scholar
  11. 11.
    Campbell JP, Leder HA, Sepah YJ, Gan T, Dunn JP, Hatef E, Cho B, Ibrahim M, Bittencourt M, Channa R, Do DV, Nguyen QD (2012) Wide-field retinal imaging in the management of noninfectious posterior uveitis. Am J Ophthalmol 154(5):908–911CrossRefPubMedGoogle Scholar
  12. 12.
    Read RW, Holland GN, Rao NA, Tabbara KF, Ohno S, Arellanes-Garcia L, Pivetti-Pezzi P, Tessler HH, Usui M (2001) Revised diagnostic criteria for Vogt-Koyanagi-Harada disease: report of an international committee on nomenclature. Am J Ophthalmol 131(5):647–652CrossRefPubMedGoogle Scholar
  13. 13.
    Holland GN, Buhles WC Jr, Mastre B, Kaplan HJ (1989) A controlled retrospective study of ganciclovir treatment for cytomegalovirus retinopathy. Use of a standardized system for the assessment of disease outcome. UCLA CMV Retinopathy. Study Group. Arch Ophthalmol 107(12):1759–1766CrossRefPubMedGoogle Scholar
  14. 14.
    Abu El-Asrar AM, Al Tamimi M, Hemachandran S, Al-Mezaine HS, Al-Muammar A, Kangave D (2013) Prognostic factors for clinical outcomes in patients with Vogt-Koyanagi-Harada disease treated with high-dose corticosteroids. Acta Ophthalmol 91(6):e486–e493CrossRefPubMedGoogle Scholar
  15. 15.
    Jap A, Luu CD, Yeo I, Chee SP (2008) Correlation between peripapillary atrophy and corticosteroid therapy in patients with Vogt-Koyanagi-Harada disease. Eye (Lond) 22(2):240–245CrossRefGoogle Scholar
  16. 16.
    Guo YL, Du Y, He JF (2009) Correlation between sunset glow fundus and initial dosage of corticosteroid in patients with Vogt-Koyanagi-Harada disease. Am J Ophthalmol 947(5):946–947CrossRefGoogle Scholar
  17. 17.
    Inomata H, Rao NA (2001) Depigmented atrophic lesions in sunset glow fundi of Vogt-Koyanagi-Harada disease. Am J Ophthalmol 131(5):607–614CrossRefPubMedGoogle Scholar
  18. 18.
    Rao NA, Wu GS (2000) Free radical mediated photoreceptor damage in uveitis. Prog Retin Eye Res 19(1):41–68CrossRefPubMedGoogle Scholar
  19. 19.
    Suzuki S (1999) Quantitative evaluation of “sunset glow” fundus in Vogt-Koyanagi-Harada disease. Jpn J Ophthalmol 43(4):327–333CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2014

Authors and Affiliations

  • Eun Kyoung Lee
    • 1
  • Sang-Yoon Lee
    • 1
  • Hyeong Gon Yu
    • 1
  1. 1.Department of OphthalmologySeoul National University College of Medicine, Seoul National University HospitalSeoulRepublic of Korea

Personalised recommendations